Marcum Wealth LLC Has $460,000 Stake in CME Group Inc. (NASDAQ:CME)

Marcum Wealth LLC increased its position in CME Group Inc. (NASDAQ:CMEGet Rating) by 31.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,247 shares of the financial services provider’s stock after buying an additional 538 shares during the quarter. Marcum Wealth LLC’s holdings in CME Group were worth $460,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in CME. People s United Financial Inc. boosted its holdings in shares of CME Group by 45.2% during the 4th quarter. People s United Financial Inc. now owns 6,979 shares of the financial services provider’s stock worth $1,594,000 after buying an additional 2,174 shares in the last quarter. Fiduciary Trust Co. lifted its holdings in shares of CME Group by 1.9% in the 4th quarter. Fiduciary Trust Co. now owns 3,021 shares of the financial services provider’s stock worth $690,000 after purchasing an additional 55 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in CME Group in the 4th quarter valued at $255,000. Nissay Asset Management Corp Japan ADV raised its position in CME Group by 3.1% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 38,568 shares of the financial services provider’s stock valued at $8,811,000 after buying an additional 1,172 shares during the last quarter. Finally, LPL Financial LLC raised its position in CME Group by 10.1% in the 4th quarter. LPL Financial LLC now owns 66,711 shares of the financial services provider’s stock valued at $15,241,000 after buying an additional 6,112 shares during the last quarter. Institutional investors and hedge funds own 85.56% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $183.33 on Friday. The company has a market cap of $65.90 billion, a PE ratio of 22.75, a price-to-earnings-growth ratio of 2.93 and a beta of 0.40. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a 50-day moving average price of $198.51 and a 200-day moving average price of $210.51. CME Group Inc. has a 12-month low of $181.29 and a 12-month high of $256.94.

CME Group (NASDAQ:CMEGet Rating) last issued its quarterly earnings results on Wednesday, July 27th. The financial services provider reported $1.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.05. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.25 billion. CME Group had a return on equity of 9.65% and a net margin of 60.43%. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter last year, the company posted $1.64 EPS. As a group, equities analysts forecast that CME Group Inc. will post 7.96 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 27th. Investors of record on Friday, September 9th will be issued a dividend of $1.00 per share. The ex-dividend date of this dividend is Thursday, September 8th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.18%. CME Group’s dividend payout ratio is 49.63%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. UBS Group decreased their target price on CME Group from $246.00 to $240.00 and set a “buy” rating for the company in a research report on Tuesday, August 2nd. Raymond James lowered CME Group from an “outperform” rating to a “market perform” rating in a research report on Monday, August 15th. Jefferies Financial Group assumed coverage on CME Group in a research report on Tuesday, May 31st. They set a “buy” rating and a $267.00 target price for the company. Morgan Stanley decreased their target price on CME Group from $242.00 to $226.00 and set an “equal weight” rating for the company in a research report on Thursday, July 28th. Finally, Atlantic Securities raised CME Group from a “neutral” rating to an “overweight” rating and set a $235.00 price objective for the company in a report on Friday, June 10th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $230.80.

Insider Activity at CME Group

In related news, Director Daniel R. Glickman sold 500 shares of the firm’s stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total transaction of $98,195.00. Following the transaction, the director now directly owns 14,597 shares of the company’s stock, valued at approximately $2,866,704.83. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other CME Group news, Director Daniel R. Glickman sold 500 shares of CME Group stock in a transaction that occurred on Wednesday, August 31st. The stock was sold at an average price of $196.39, for a total value of $98,195.00. Following the transaction, the director now directly owns 14,597 shares of the company’s stock, valued at approximately $2,866,704.83. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Hilda Harris Piell sold 4,901 shares of CME Group stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $203.88, for a total value of $999,215.88. Following the completion of the transaction, the insider now directly owns 33,140 shares in the company, valued at $6,756,583.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,511 shares of company stock valued at $2,123,186. Corporate insiders own 0.30% of the company’s stock.

About CME Group

(Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.